Technical Analysis for AURA - Aura Biosciences, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Flat |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 20 DMA | Bearish | 1.62% | |
| NR7 | Range Contraction | 1.62% | |
| Narrow Range Bar | Range Contraction | 1.62% | |
| Doji - Bullish? | Reversal | 1.62% | |
| Down 3 Days in a Row | Weakness | 1.62% | |
| Gapped Down | Weakness | 1.62% | |
| Earnings Movers | Other | 0.27% | |
| Fell Below 50 DMA | Bearish | -2.47% | |
| Upper Bollinger Band Walk | Strength | -2.47% | |
| Earnings Movers | Other | -2.47% |
| Alert | Time |
|---|---|
| 20 DMA Support | about 3 hours ago |
| Rose Above 20 DMA | about 4 hours ago |
| Rose Above Previous Day's High | about 4 hours ago |
| 10 DMA Resistance | about 4 hours ago |
| Up 3% | about 4 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/06/2024
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform to treat tumors of high unmet need in ocular and urologic oncology. Its AU-011, a VDC candidate, is being developed for the first line treatment of primary choroidal melanoma, a rare disease with no drugs approved. The company also develops AU-011 in additional ocular oncology indications, including choroidal metastases. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Tumor Rare Diseases Melanoma Neoplasms Uveal Melanoma
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Tumor Rare Diseases Melanoma Neoplasms Uveal Melanoma
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 13.5 |
| 52 Week Low | 5.9906 |
| Average Volume | 193,039 |
| 200-Day Moving Average | 8.72 |
| 50-Day Moving Average | 7.77 |
| 20-Day Moving Average | 7.39 |
| 10-Day Moving Average | 7.51 |
| Average True Range | 0.36 |
| RSI (14) | 46.81 |
| ADX | 16.94 |
| +DI | 27.79 |
| -DI | 21.42 |
| Chandelier Exit (Long, 3 ATRs) | 7.06 |
| Chandelier Exit (Short, 3 ATRs) | 7.95 |
| Upper Bollinger Bands | 7.91 |
| Lower Bollinger Band | 6.87 |
| Percent B (%b) | 0.5 |
| BandWidth | 14.05 |
| MACD Line | -0.02 |
| MACD Signal Line | -0.08 |
| MACD Histogram | 0.0551 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 7.60 | ||||
| Resistance 3 (R3) | 7.61 | 7.54 | 7.57 | ||
| Resistance 2 (R2) | 7.54 | 7.49 | 7.54 | 7.55 | |
| Resistance 1 (R1) | 7.47 | 7.46 | 7.51 | 7.46 | 7.54 |
| Pivot Point | 7.40 | 7.40 | 7.42 | 7.40 | 7.40 |
| Support 1 (S1) | 7.33 | 7.35 | 7.37 | 7.32 | 7.24 |
| Support 2 (S2) | 7.26 | 7.32 | 7.26 | 7.23 | |
| Support 3 (S3) | 7.19 | 7.26 | 7.22 | ||
| Support 4 (S4) | 7.18 |
